ISSN: 1948-5964
+44 1300 500008
Arterez Inc, White Lake, Michigan, United States
Josefino B. Tunac works at Arterez Inc, White Lake, Michigan, United States. His area of research interests includes Infectious diseases, Virology. He /she has authored of many research articles/books in the relevant areas.
Research Article
A Combo Compound Therapy Effectively Reduces SARS-CoV-1 Viral Load in Mouse Lung
Author(s): Josefino B. Tunac*
Objective: SARS-CoV disease caused by SARS-CoV-1 is of multifactorial etiology consisting of upstream and
downstream phases. The upstream phase is the physical breach of the cells protective shield by extraneous stressors
including the virus and environmental elements (xeno), while the downstream is a sequela of damages (plexic)
manifested in various symptoms, herein called xenoplexic diseases. Symptom targeting drugs are ineffective and
palliative at best. SARS-CoV is a xenoplexic disease best treated with a combo therapeutic strategy This study
evaluates EmbotricinTM (EMB), a multicomponent compound, to treat SARS-CoV.
Materials and methods: Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-1), strain Urbani (200300592),
obtained from the Centers for Disease Control and Prevention (CDC, Atlanta, GA) was use.. View More»
DOI:
10.37421/1948-5964.21.13.221